Calls for Proposals Early-stage FY 2019 Infectious Diseases and Immunology Research: U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards, 2019
|Status of Grants/Funding Opportunities||Grants/Funding Opportunities|
|R&D phase||Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, Clinical Research|
|Key Fields||Emerging/ Re-Emerging Infectious Disease Project Of Japan(1st), Other programs(1st)|
|Submission Deadline||12/14/18 Fri (23:59 pm)|
Public offering content
Japan Agency for Medical Research and Development (AMED), in collaboration with U.S. National Institute of Allergy and Infectious Diseases (NIAID), is pleased to announce the joint request for proposals on "Viral Diseases and Immunology Research: U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards, 2019."
- (1) Research areas
- Infectious Diseases and Immunology
- (2) Project size
- 6 million yen for 2 year of support (including indirect cost)
AMED needs to contract with the Japan sub teams in every fiscal year. 70 % of the total research budget for Japanese sub team is granted in 1st fiscal year, JFY 2019, and rest of the research budget (30%) is granted in 2nd fiscal year, in JFY 2020
- (3) Research period
- JFY 2019~JFY 2020
- (4) Number of projects to be awarded
- 0-8 projects (expected)
For details please refer to the complete Request for Proposals:
Overview of US-Japan Cooperative Medical Sciences Program
The U.S.-Japan Cooperative Medical Sciences Program (USJCMSP), one of the oldest bilateral programs in the history of NIH, was established in 1965 (under a U.S. Presidential-Japan Prime Ministerial level agreement) to strengthen Japanese research capacity and address issues of public health importance in the Asia Pacific region. The program continues to maintain its value as a unique tool to foster U.S., Japan, and Asia Pacific Region research collaboration. For more information visit:
- Collaborative research teams consisting of investigators from (1) the U.S. and Japan, or (2) the U.S., Japan, and other Asia Pacific countries, are eligible to apply.
- On each application it is strongly encouraged that both of the Japanese sub-team and U.S sub team as a PI an early-stage or female investigator. At least, either of the Japanese sub-team or the U.S. sub-team must include as a Principal investigator (PI) an early-stage or female investigator.
For complete eligibility requirements, please refer to the Request for Proposals.
In addition to submission through CRDF Global's application portal, applicants in Japanese sub-teams are required to complete e-Rad submission no later than Friday, December 14, 2018 (12:00 pm) Japan Time.
How to Apply
To apply, please follow the information on the Request for Proposals and the AMED Supplemental Application Guideline for Japanese Sub-teams (in Japanese).
Last updated 10/17/18